MRX2843

· Betta Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MRX2843, covering 2021-07-01 to 2021-07-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MRX2843 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]